Vitroprobe
1 known investors
Vitroprobe Analytics develops a patented biomolecular analysis method using Atom Probe Tomography to examine drug targets and their interactions at near-atomic resolution, helping pharmaceutical developers design and fine-tune new drugs. The company works in collaboration with academia and industry and originated from research at Chalmers University of Technology.
Founders & leadership
MA
Martin AnderssonChairman, Co-founder
MH
Mats HulanderCo-founder
GS
Gustav SundellCo-founder
Investors · 1
Frequently asked questions
- What does Vitroprobe do?
- Vitroprobe Analytics develops a patented biomolecular analysis method using Atom Probe Tomography to examine drug targets and their interactions at near-atomic resolution, helping pharmaceutical developers design and fine-tune new drugs. The company works in collaboration with academia and industry and originated from research at Chalmers University of Technology.
- Who founded Vitroprobe?
- Vitroprobe was founded by Martin Andersson, Mats Hulander, Gustav Sundell.
- Who are Vitroprobe's investors?
- Vitroprobe's investors include Chalmers Ventures AB.